MEETINGS - German BVMed industry association's 2007 innovation forum (Germany) September 2007:
This article was originally published in Clinica
Executive Summary
HTA - help or hindrance to innovations in the inpatient setting? is the theme of the German BVMed industry association's 2007 innovation forum, on September 12. The health ministry's Ferdinand Rau; Helios Kliniken's Adelheid Jakobs-Schafer and Prof Josef Zacher; and university of Hanover representatives Christophe Vauth and Prof J-Mattias Graf von der Schulenburg will be among the panel of speakers who will also address the theme of financing of inpatient procedures in the DRG era as of 2009. The free-of-charge event, in Berlin, is open to health economy specialists who are interested in medtech advances, as well as association members. See: www.bvmed.de
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.